Dr Paul Quinn is currently Senior Clinical Program Director at Shire Pharmaceuticals based in Basingstoke, UK. In his role Paul is accountable globally for the design, delivery of all Phase II – IV clinical studies sponsored by Shire Pharmaceuticals. The Shire model is to outsource the execution of studies to CROs and the Clinical Programs group is responsible for the oversight and management of these clinical CROs. Prior to his current role Paul worked in Clinical Development at Pfizer as a Director. Here he was responsible for the design and delivery of Phase 2b and Phase 3 trials in both Irritable Bowel Syndrome, Overactive Bladder and Sexual Health. This culminated in the successful filing of darifenacin (Enablex) for the treatment of Overactive Bladder. Paul has also pioneered the use innovative trial designs and technologies including electronic data capture and electronic patient diaries to ensure optimal delivery of clinical trials. Paul has both a degree in Pharmacology and Physiology from Manchester University and a PhD in Physiology from the University of Leicester.
Appearing:
Day 1 Stream 2: Clinical outsourcing performance management
11.15am
Managing your vendor – what are the options for the project team?
Objectives of vendor management
Tools in the vendor management process
CRO – sponsor interface
The role of the relationship management committees
Jane Clarke
